Melissa A. Schiff

Papers

Total Citations

H-Index

About

Melissa A. Schiff is a leading researcher in gynecologic oncology, with a focus on optimizing surgical and treatment strategies for aggressive uterine cancers. Her work centers on improving outcomes for rare but deadly endometrial cancer subtypes, such as uterine papillary serous carcinoma (UPSC) and uterine clear cell carcinoma (UCCC), which contribute disproportionately to endometrial cancer deaths. In her highly cited 2015 study, she analyzed treatment practices at two high-volume cancer centers, revealing critical gaps in evidence-based care for these high-risk patients—a study that has garnered 45 citations and shaped clinical discussions. Schiff’s 2018 comparative analysis of robotic, laparoscopic, and open hysterectomy for endometrial cancer (37 citations) provided pivotal data on surgical outcomes, helping to guide minimally invasive approaches while balancing oncologic safety. Her research directly impacts surgical decision-making and treatment protocols, offering actionable insights for clinicians managing complex endometrial cancers. Through these contributions, Schiff has advanced the field’s understanding of how to tailor aggressive therapies and surgical techniques to improve survival and quality of life for patients with the most challenging uterine malignancies.